Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Corradini

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Leukemia|December 22, 2017
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myelomaS Bringhen, M D'Agostino, L De Paoli, et al.
Bone Marrow Transplantation|April 26, 2020
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)A Olivieri, G Mancini, J Olivieri, et al.
Bone Marrow Transplantation|February 8, 2005
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplantsG Gahrton, S Iacobelli, J Apperley, et al.
Bone Marrow Transplantation|June 8, 2006
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myelomaN W C J van de Donk, N Kröger, U Hegenbart, et al.
Hematological Oncology|September 21, 2024
Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implicationsN Polverelli, M Anghilieri, C Elena, et al.
Bone Marrow Transplantation|January 27, 2015
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trialS Iacobelli, L C de Wreede, S Schönland, et al.
Leukemia|March 2, 2012
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patientsA Rambaldi, A Bacigalupo, R Fanin, et al.
Leukemia|June 8, 2007
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)C Tarella, M Zanni, M Di Nicola, et al.
Leukemia|December 7, 2017
Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell linesF Maura, M Petljak, M Lionetti, et al.
Leukemia|July 10, 2013
The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo OsseoE Todisco, F Ciceri, E Oldani, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Leukemia|December 22, 2017
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myelomaS Bringhen, M D'Agostino, L De Paoli, et al.
Bone Marrow Transplantation|April 26, 2020
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)A Olivieri, G Mancini, J Olivieri, et al.
Bone Marrow Transplantation|February 8, 2005
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplantsG Gahrton, S Iacobelli, J Apperley, et al.
Bone Marrow Transplantation|June 8, 2006
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myelomaN W C J van de Donk, N Kröger, U Hegenbart, et al.
Hematological Oncology|September 21, 2024
Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implicationsN Polverelli, M Anghilieri, C Elena, et al.
Bone Marrow Transplantation|January 27, 2015
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trialS Iacobelli, L C de Wreede, S Schönland, et al.
Leukemia|March 2, 2012
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patientsA Rambaldi, A Bacigalupo, R Fanin, et al.
Leukemia|June 8, 2007
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)C Tarella, M Zanni, M Di Nicola, et al.
Leukemia|December 7, 2017
Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell linesF Maura, M Petljak, M Lionetti, et al.
Leukemia|July 10, 2013
The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo OsseoE Todisco, F Ciceri, E Oldani, et al.
Pageof 12